Short-term cognitive behavioral therapy (CBT) given by primary health care workers with patients with chronic benzodiazepine use and new patients in the family practice with sleepinsdisorder, hypothised that CBT results in reduction of…
ID
Bron
Aandoening
sleepingdisorder, slaapstoornissen
Ondersteuning
Scientific Institute for Quality of Healthcare (IQ healthcare)
Postbus 9101, huispost 114
6500 HB Nijmegen
The Netherlands
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Benzodiazepine prescription.
Achtergrond van het onderzoek
Background:
Cognitive behavioral therapy shows to be an effective way to treat patients with sleepingdisorder. In this study primairy health care workers are trained to use CBT with patients with sleepingdisorder.
Objective:
Reduction of benzodiazepine prescription and improved sleeping behavior.
Methods:
Extraction from Electronic Medical System (HIS) and questionnaires (before and after CBT).
Intervention:
Patients with sleeping disorders (new episode or chronic benzodiazepine use) are invited to make use of CBT by primary health care worker. CBT include 6 sessions and the use of a sleepdairy.
Results: not yet available.
Recruitment: the Netherlands.
Doel van het onderzoek
Short-term cognitive behavioral therapy (CBT) given by primary health care workers with patients with chronic benzodiazepine use and new patients in the family practice with sleepinsdisorder, hypothised that CBT results in reduction of benzodiazepine prescription and improved sleeping behavior.
Onderzoeksopzet
Benzodiazepine prescription:
Extraction from Electronic Medical System (HIS). Two times with a 6 months interval (sept. 2009 and march 2010).
Outcomes related to the sleepingdisorder:
Questionnaires two times with a 3 months interval for each patient (before and after CBT).
Onderzoeksproduct en/of interventie
Patients with sleeping disorders (new episode or chronic benzodiazepine use) are invited to make use of CBT by primary health care worker. CBT includes 6 sessions and the use of a sleepdairy. The controle group receive usual care.
Algemeen / deelnemers
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Wetenschappers
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Patients with chronic benzodiazepine use;
2. New patients who come to the general practitioner with sleepingdisorder.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Current psychiatric treatment;
2. Drug or alcohol dependency treatment;
3. Psychosis in medical history;
4. Epilepsy;
5. Terminal disease;
6. Do not speak the Dutch language;
7. Other criteria each individual general practitioner use .
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL1903 |
| NTR-old | NTR2019 |
| Ander register | METC Radboud University : 2009/089 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |